Trovagene Inc (NASDAQ:TROV)

9.53
Delayed Data
As of Jul 02
 -0.19 / -1.95%
Today’s Change
2.97
Today|||52-Week Range
13.58
+121.63%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close9.72
Today’s open9.76
Day’s range9.34 - 9.76
Volume384,516
Average volume (3 months)621,113
Market cap$233.1M
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-25.71%
Earnings growth (this year)-33.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+8.07%
P/E ratioNM
Price/Sales292.69
Price/Book21.59

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...+0.35+5.54%
QTNTQuotient Ltd+0.36+2.40%
VCYTVeracyte Inc-0.32-3.02%
OXFDOxford Immunotec Glo...-0.24-1.85%
Data as of 3:59pm ET, 07/02/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$280.2K
Annual profit (last year)-$14.3M
Net profit margin-5,112.99%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers